Economic analysis of alvimopan in North American Phase III efficacy trials. (Q45918531)

17 December 2017

title

Economic analysis of alvimopan in North American Phase III efficacy trials. (English)

1 reference

17 December 2017

main subject

phase III clinical trial

0 references

1 reference

Timothy J Bell

1

1 reference

17 December 2017

Sara A Poston

2

1 reference

17 December 2017

Michael D Kraft

3

1 reference

17 December 2017

Anthony J Senagore

4

1 reference

17 December 2017

Conor P Delaney

5

1 reference

17 December 2017

Lee Techner

6

1 reference

17 December 2017

publication date

1 August 2009

1 reference

17 December 2017

American Journal of Health-System Pharmacy

published in

1 reference

17 December 2017

volume

66

1 reference

17 December 2017

issue

15

1 reference

17 December 2017

page(s)

1362-1368

1 reference

17 December 2017

Postoperative ileus: etiologies and interventions

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080329

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080329

Analgesic agents for the postoperative period. Opioids

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080329

Review of postoperative ileus

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080329

Causes of increased hospital stay after radical cystectomy in a clinical pathway setting

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080329

Postoperative upper and lower gastrointestinal recovery and gastrointestinal morbidity in patients undergoing bowel resection: pooled analysis of placebo data from 3 randomized controlled trials

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080329

Multivariable analysis of factors associated with hospital readmission after intestinal surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080329

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080329

Postoperative ileus-related morbidity profile in patients treated with alvimopan after bowel resection

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080329

The surgical team and outcomes management: focus on postoperative ileus

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080329

Alvimopan: a peripherally acting mu-opioid receptor antagonist

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080329

Clinical costs of feeding tube placement.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080329

Indications for total parenteral nutrition in the hospitalized patient: a prospective review of evolving practice

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080329

Phase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080329

Gastrointestinal tract recovery in patients undergoing bowel resection: results of a randomized trial of alvimopan and placebo with a standardized accelerated postoperative care pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080329

Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: results of a randomized, double-blind, controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080329

Clinical trial: alvimopan for the management of post-operative ileus after abdominal surgery: results of an international randomized, double-blind, multicentre, placebo-controlled clinical study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080329

Alvimopan, for postoperative ileus following bowel resection: a pooled analysis of phase III studies

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080329

31 March 2020

Identifiers

DOI

10.2146/AJHP080329

1 reference

17 December 2017

1 reference

17 December 2017